top of page
Recent Posts
Search

Pediatrics Study Discredits “Kind and Gentle” Chemo Approach for Kids with Leukemia

  • OPACC
  • Nov 20, 2012
  • 1 min read

For decades, children have received chemotherapy over days, rather than minutes, under the assumption the “kinder and gentler” approach would protect their hearts from long-term, often deadly, cardiac complications associated with the potent drugs.

But a study led by Miller School researchers and published online today in the journal Pediatrics found that the slow, continuous infusion of doxorubicin, a drug that has dramatically improved the leukemia survival rate, does not provide youngsters with acute lymphoblastic leukemia (ALL) any more cardioprotection than rapid infusion.

Both infusion methods, the multicenter study found, are equally toxic to young hearts.

Recent Posts

See All
Archive
Search By Tags
Rama logo.png
cgcg logo.jpg

524 Bayfield Street North
P.O. Box 20005
Barrie, ON L4M 5E9
Canada

info@opacc.org

705-828-7965

  • Wix Facebook page
  • Wix Twitter page
  • Instagram Social Icon
  • YouTube Social  Icon
bottom of page